Column Group IV GP, LP bought EIKN
September 3, 2026 · Form 4 insider transaction
Column Group IV GP, LP bought 89,200 shares of Eikon Therapeutics, Inc. at $11.56 per share, a transaction worth $1.03M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
The price reported in column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $11.17 to $11.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.; The securities are directly held by Peter Svennilson.